BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25828844)

  • 1. Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases.
    Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Takamura K; Hanaoka M; Nishimura M; Tatsumi K;
    Respirology; 2015 Jul; 20(5):805-12. PubMed ID: 25828844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases.
    Tanabe N; Kumamaru H; Tamura Y; Taniguchi H; Emoto N; Yamada Y; Nishiyama O; Tsujino I; Kuraishi H; Nishimura Y; Kimura H; Inoue Y; Morio Y; Nakatsumi Y; Satoh T; Hanaoka M; Kusaka K; Sumitani M; Handa T; Sakao S; Kimura T; Kondoh Y; Nakayama K; Tanaka K; Ohira H; Nishimura M; Miyata H; Tatsumi K;
    Circ J; 2021 Mar; 85(4):333-342. PubMed ID: 33536399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
    Suzuki Y; Nagaoka T; Terayama Y; Nagata Y; Yoshida T; Tsutsumi T; Kuriyama S; Matsushita M; Joki Y; Takasu K; Konishi H; Takahashi K
    Respir Investig; 2024 Jan; 62(1):167-175. PubMed ID: 38142548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
    Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
    J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease.
    Cottin V; Nunes H; Mouthon L; Gamondes D; Lazor R; Hachulla E; Revel D; Valeyre D; Cordier JF;
    Arthritis Rheum; 2011 Jan; 63(1):295-304. PubMed ID: 20936629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study.
    Stącel T; Urlik M; Nęcki M; Antończyk R; Latos M; Wajda-Pokrontka M; Tatoj Z; Zawadzki F; Przybyłowski P; Zembala M; Ochman M
    Transplant Proc; 2020 Sep; 52(7):2101-2109. PubMed ID: 32336653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.
    Zhang L; Zhang C; Dong F; Song Q; Chi F; Liu L; Wang Y; Che C
    BMC Pulm Med; 2016 Nov; 16(1):137. PubMed ID: 27809901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
    Hata A; Sekine Y; Kota O; Koh E; Yoshino I
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1261-8. PubMed ID: 27354784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
    Tanaka M; Koike R; Sakai R; Saito K; Hirata S; Nagasawa H; Kameda H; Hara M; Kawaguchi Y; Tohma S; Takasaki Y; Dohi M; Nishioka Y; Yasuda S; Miyazaki Y; Kaneko Y; Nanki T; Watanabe K; Yamazaki H; Miyasaka N; Harigai M
    Mod Rheumatol; 2015 Jul; 25(4):609-14. PubMed ID: 25496409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.
    Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K;
    Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Vizza CD; Hoeper MM; Huscher D; Pittrow D; Benjamin N; Olsson KM; Ghofrani HA; Held M; Klose H; Lange T; Rosenkranz S; Dumitrescu D; Badagliacca R; Claussen M; Halank M; Vonk-Noordegraaf A; Skowasch D; Ewert R; Gibbs JSR; Delcroix M; Skride A; Coghlan G; Ulrich S; Opitz C; Kaemmerer H; Distler O; Grünig E
    Chest; 2021 Aug; 160(2):678-689. PubMed ID: 33581097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.
    Zimmermann GS; von Wulffen W; Huppmann P; Meis T; Ihle F; Geiseler J; Leuchte HH; Tufman A; Behr J; Neurohr C
    Respirology; 2014 Jul; 19(5):700-6. PubMed ID: 24697923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
    Portillo K; Torralba Y; Blanco I; Burgos F; Rodriguez-Roisin R; Rios J; Roca J; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1313-20. PubMed ID: 26203238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema.
    Mori K; Shirai T; Mikamo M; Shishido Y; Akita T; Morita S; Asada K; Fujii M; Hozumi H; Suda T; Chida K
    Respir Physiol Neurobiol; 2013 Jan; 185(2):235-40. PubMed ID: 23117106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.